COMPANY PROFILE

DE Group

Explore full profile

Pharmaceutical wholesalers, offering our customers a full line range of generics

Prudhoe, United KingdomFounded 1995Biotech & Life Sciences

Valuation $250–500M Last recorded · 2013

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About DE Group

DE Group is a prominent independent pharmaceutical distributor dedicated to serving the independent community pharmacy sector in the UK. With no retail presence, DE Group ensures that it does not compete with its customers, providing an unbiased service. The company operates through a network of 9 strategically located depots, enabling twice-daily deliveries to most parts of the UK. DE Group's business model revolves around supplying a full line of generic pharmaceuticals to over 4,500 independent community pharmacies. The company employs a field-based sales force of over 40 representatives and has more than 140 dedicated salespeople, ensuring personalized service and support. DE Group generates revenue by acting as a supply chain partner for pharmaceutical manufacturers, facilitating the distribution of their products to community pharmacies.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 1995
Headquarters: Prudhoe, United Kingdom
Employees: 42
Open positions: None listed
Dealroom signal: 22.3/100
Industry: Health, Wellness Beauty
Sub-industry: Pharmaceutical
Sector: Biotech & Life Sciences, Wholesale, Biotechnology, Biotech and Pharma, Hard Tech, uk is8 life sciences
Client focus: b2c
Links: Website X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

1 recorded event

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SEED✓Equity / VC	Oct 2013	$49M	$195M	Royal Bank of Scotland (RBS)	—

Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

DE Group website traffic

Latest recorded traffic for DE Group is 420 monthly website visits, down 27.6% over the last three months. DE Group's team grew 0% over the past year.

Latest monthly visits420 3-month web change-27.6% 1-year team growth0%

Monthly website visitsOct 2017–Feb 2025

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
OXOxtoxProducing medical grade vitamins and shakes, for optimal health, weight loss and immune system support	Oxford, United Kingdom	Closed	1	$792K	$3.2M
B®Botanica ®The world's first carbon-negative medical cannabis product wholesaler	London, United Kingdom	Operational
OXOxocanA health-driven wellness tech company renowned for pharma-grade GMP-Certified CBD products	London, United Kingdom	Operational
DIDIADEMImproves clinicians/patient understanding about risk of Dementia/Alzheimer’s to enable earlier decisions and outcome	London, United Kingdom	Operational
BABase4Microdroplet-based single molecule DNA sequencing technology.	Cambridge, United Kingdom	Operational
CPCOMPASS PathwaysPsilocybin-based therapies for treatment-resistant mental health conditions	London, United Kingdom	Operational
ZIZiyloDeveloping synthetic molecules that are selective for glucose in blood	Bristol, United Kingdom	Acquired
REReViralAntiviral therapeutics targeting respiratory syncytial virus (RSV)	Stevenage, United Kingdom	Acquired